Cereset for Caregiver Stress
(CERESET Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test the feasibility of using Cereset, an acoustic stimulation therapy, to help caregivers manage stress. It targets those caring for patients recently diagnosed with high-grade glioma, a type of brain cancer. Participants will undergo five in-office Cereset sessions and use a wearable device for additional therapy during routine radiation sessions. Ideal candidates are primary caregivers who provide most of the support for someone with a high-grade glioma diagnosis. As an unphased trial, this study offers caregivers a unique opportunity to explore innovative stress management techniques.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you have a seizure disorder requiring ongoing anti-epileptic medication, you may not be eligible to participate.
What prior data suggests that the Cereset intervention is safe for caregivers?
Research shows that the Cereset treatment has been tested in people with conditions like PTSD, insomnia, and stress. Studies have found that Cereset uses sound to help the brain reset, which can be calming. Although specific safety information for caregivers is still being collected, the treatment has been used in other groups without serious problems. Past patients have not reported major side effects. This suggests that Cereset is generally safe, but ongoing studies will provide more detailed safety information.12345
Why are researchers excited about this trial?
Unlike standard treatments for caregiver stress, which often involve counseling, medication, or stress management techniques, Cereset offers a unique approach by using brainwave technology. Cereset is a non-invasive therapy that helps the brain rebalance itself through audio tones, potentially providing a calming effect without the need for pharmaceuticals. Researchers are excited about Cereset because it offers a new way to address stress by directly interacting with brain activity, which could lead to quicker and more sustained relief for caregivers under significant stress.
What evidence suggests that the Cereset intervention is effective for caregiver stress?
Research has shown that Cereset, a non-invasive technology, may help reduce stress and improve sleep. Studies have found it can assist people with PTSD, insomnia, and other stress-related issues. Early findings suggest that Cereset lowers stress by using sound to balance brain activity. In this trial, caregivers of participants with high-grade glioma will undergo Cereset treatment. Similar methods have greatly reduced stress levels over a few months in previous studies. While more research is needed, early results are promising for those feeling overwhelmed by caregiving duties.12346
Who Is on the Research Team?
Roy Strowd, MD
Principal Investigator
Wake Forest University Health Sciences
Are You a Good Fit for This Trial?
This trial is for adults over 18 who are the primary caregivers for patients with high-grade gliomas, such as astrocytoma or glioblastoma. Caregivers must be able to sit in a chair for 90 minutes and sign consent forms. They can't have used certain brain stimulation therapies recently, have severe hearing loss, weigh over 400 pounds, or be unable to abstain from alcohol or drugs during the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Cereset Research Office Intervention
Participants undergo standard Cereset Research Office (CRO) in-office treatment for a total of five treatments
Ambulatory Therapy
Ambulatory therapy with the Cereset Research Wearable (CRW) available to caregivers during routine radiation therapy with glioma patients
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Cereset
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor